# EGFR activation limits the response of liver cancer to lenvatinib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/egfr-activation-limits-the-response-of-liver-cancer-to-lenvatinib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Haojie Jin,Yao Shi,Yuanyuan Lv,Shengxian Yuan,Christel Ramirez,Cor Lieftink,Liqin Wang,Siying Wang,Cun Wang,Matheus Henrique Dias,Fleur Jochems,Yuan Yang,Astrid Bosma,E. Marielle Hijmans,Marnix H. P. de Groot,Serena Vegna,Dan Cui,Yangyang Zhou,Ling Jing,Hui Wang,Yuchen Guo,Xingling Zheng,Nikita Isima,Hai-Qiu Wu,Chong Sun,Roderick L. Beijersbergen,Leila Akkari,Weiping Zhou,Bo Zhai,Wenxin Qin,René Bernards |
| Citations | 440 |
| DOI | 10.1038/s41586-021-03741-7 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3183709015 |
| PMID | 34290403 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Bo Zhai](https://scholariq.org/researchers/bo-zhai/)

## Paper journal

- [Nature](https://scholariq.org/journals/nature/)

## Paper primary topic

- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)

## Paper topics

- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.